Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 11Thoracic 7Gastrointestinal 6Tumor-Agnostic 1Other solid neoplasm 1Head & Neck 1Dermatologic 1Breast 1

Conditions

Skin Neoplasms 1Inflammation 1

Interventions

Ipilimumab 123pembrolizumab 101Nivolumab 100aldesleukin 89Cyclophosphamide 85fludarabine phosphate 64Interleukin-2 58Dacarbazine 573-ingenyl angelate 42Vemurafenib 39Temozolomide 39Imiquimod 39trametinib 37sargramostim 37Peripheral Blood Stem Cell Transplantation 36incomplete Freund's adjuvant 35dabrafenib 32fludarabine 31Radiotherapy 31Aminolevulinic Acid 30Bevacizumab 29Carboplatin 28Whole-Body Irradiation 25Photochemotherapy 25Paclitaxel 25Filgrastim 25Biopsy 25Interferon-alpha 24Cisplatin 23Sorafenib 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Tea × Dermatologic × Clear all
NCT01032031 2016-03-08

The Effect of Green Tea and Vitamin C on Skin Health

University of Manchester

Phase NA Completed
95 enrolled
Dermatologic

Inflammation, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡